1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. United States >
  6. California >
  7. Apricus Biosciences >
  8. M&A

Apricus Biosciences Mergers & Acquisitions

Apricus Biosciences M&A Summary

Apricus Biosciences has acquired 2 companies of its own. It has also divested 1 asset.

Apricus Biosciences has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity2
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

Apricus Biosciences

Apricus Biosciences, Inc.

11975 El Camino Real, Suite 300,
San Diego, California 92130
United States,
(858) 222-8041
www.apricusbio.com

All (3) Buy (2) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2013-04-02 Totect (dexrazoxane HCI) · Life Science
, United States · www.totect.com

Totect (dexrazoxane HCI) is an emergency medicine used to reverse the toxic effects of anthracycline anti-cancer treatment. Totect® reverses this damage, allowing patients to continue their essential anti-cancer treatment.

- Divestiture

Biocodex USA

Apricus Biosciences


Try Mergr Free — See This and 220,677+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal